Cargando…
Fludarabine, adriamycin and dexamethasone (FAD) in newly diagnosed advanced follicular lymphoma: a phase II study by the British National Lymphoma Investigation (BNLI)
The optimal first-line treatment for symptomatic patients with advanced stage follicular lymphoma remains unclear. Fludarabine-based combination regimens have been extensively used in relapsed disease and merit consideration as first-line therapy. We here report the results of a phase II study of FA...
Autores principales: | Yung, L, Cunningham, D, Hancock, B, Smith, P, Maclennan, K, Linch, D, McMillan, A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364798/ https://www.ncbi.nlm.nih.gov/pubmed/15280929 http://dx.doi.org/10.1038/sj.bjc.6602031 |
Ejemplares similares
-
Clinical stage 1 non-Hodgkin's lymphoma: long-term follow-up of patients treated by the British National Lymphoma Investigation with radiotherapy alone as initial therapy.
por: Vaughan Hudson, B., et al.
Publicado: (1994) -
Therapy of newly diagnosed follicular lymphoma
por: Westin, Jason R., et al.
Publicado: (2012) -
A randomised comparison of a third-generation regimen (PACEBOM) with a standard regimen (CHOP) in patients with histologically aggressive non-Hodgkin's lymphoma: a British National Lymphoma Investigation report.
por: Linch, D. C., et al.
Publicado: (1996) -
Genetic diversity of newly diagnosed follicular lymphoma
por: Asmann, Y W, et al.
Publicado: (2014) -
Low-grade lymphoma: Beyond fludarabine-single therapy
por: Park, Eunkyung
Publicado: (2011)